Business
‘Robust immune responses’: Oxford virus trial offers hope for elderly – The New Daily
Oxford University-AstraZeneca’s coronavirus vaccine has produced a robust immune response in elderly people, according to early test results.
The COVID-19 vaccine being developed by the University of Oxford produces an immune response in both elderly and young people and adverse reactions were lower among the elderly, British drug maker AstraZeneca says.
A vaccine that works is seen as a game-changer in the battle against the novel coronavirus, which has killed more than 1.15 million people, hammered the global economy and shuttered normal life across the world.
The Financial Times reported the vaccine, being developed by Oxford and AstraZeneca,…
-
General21 hours agoCollingwood cult hero Mason Cox not offered new contract for 2026 AFL season
-
Noosa News24 hours agoSevere thunderstorms, damaging winds and large hail forecast for Saturday evening
-
General20 hours agoJamie Melham creates Caulfield Cup history after riding Half Yours to victory
-
General19 hours agoJack Miller eyeing breakthrough MotoGP podium at Australian Grand Prix